About Vergent Bioscience
Vergent Bioscience is a private company based in Minneapolis, Minnesota. It has reported $57,046,126 raised in five offerings on Form D since June 2018.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 7, 2025 | Oct 20, 2025 | $18,673,277of $31.9M target | 20 | $933K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 3, 2025 | Feb 18, 2025amended Feb 18, 2025 | $3,750,000of $5.0M target | 5 | $750K | Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 17, 2022 | Oct 4, 2022 | $21,542,628of $22.0M target | 27 | $797K | EquityRule 506(b) | Form D ↗ |
| Nov 8, 2021 | Nov 22, 2021 | $1,163,814of $2.0M target | 16 | $72,738 | Debt, OptionsRule 506(b) | Form D ↗ |
| May 18, 2018 | Jun 1, 2018amended Sep 23, 2020 | $11,916,407fully sold | 21 | $567K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, five offerings | $57,046,126 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Vergent Bioscience's Form D filed Oct 20, 2025.
BH
Bobby Helmedag
Director
JY
Jeffrey Yurecko
Executive officer
AW
Anita Watkins
Director
JJ
John Santini, Jr.
President and director
RW
Raymond Wong
Director
DK
Douglas Kohrs
Director
Earlier filings also listed Samuel Dean Banks (director, last listed Feb 2025), Ryan Egeland (director, last listed Feb 2025), Jeffrey Julkowski (director, last listed Feb 2025), Samuel Banks (director, last listed Oct 2022) and Margo Shoup (director, last listed Oct 2022).